These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38522573)

  • 1. Strategy for the Optimization of Read-Through Therapy for Junctional Epidermolysis Bullosa with COL17A1 Nonsense Mutation.
    Sayar SB; Has C
    J Invest Dermatol; 2024 Oct; 144(10):2221-2229.e1. PubMed ID: 38522573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a Novel COL17A1 Compound Heterozygous Mutation in a Chinese Girl with Non-Herlitz Junctional Epidermolysis Bullosa.
    Yao YY; Zhang Y; Xie XH; Chen L; Zhu F; Zhou M
    Curr Med Sci; 2020 Aug; 40(4):795-800. PubMed ID: 32862392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Silent COL17A1 Variant Alters Splicing and Causes Junctional Epidermolysis Bullosa.
    Hoffmann J; Casetti F; Reimer A; Leppert J; Grüninger G; Has C
    Acta Derm Venereol; 2019 Apr; 99(4):460-461. PubMed ID: 30673110
    [No Abstract]   [Full Text] [Related]  

  • 4. Read-Through for Nonsense Mutations in Type XVII Collagen‒Deficient Junctional Epidermolysis Bullosa.
    Has C; Sayar SB; Zheng S; Chacón-Solano E; Condrat I; Yadav A; Roberge M; Larcher Laguzzi F
    J Invest Dermatol; 2022 Apr; 142(4):1227-1230.e4. PubMed ID: 34673051
    [No Abstract]   [Full Text] [Related]  

  • 5. Gentamicin induces COL17A1 nonsense mutation readthrough in junctional epidermolysis bullosa.
    Li Y; Shen J; Liang J; Zheng L; Chen F; Yao Z; Li M
    J Dermatol; 2020 Mar; 47(3):e82-e83. PubMed ID: 31919892
    [No Abstract]   [Full Text] [Related]  

  • 6. Paired nicking-mediated COL17A1 reframing for junctional epidermolysis bullosa.
    Bischof J; March OP; Liemberger B; Haas SA; Hainzl S; Petković I; Leb-Reichl V; Illmer J; Korotchenko E; Klausegger A; Hoog A; Binder HM; Garcia M; Duarte B; Strunk D; Larcher F; Reichelt J; Guttmann-Gruber C; Wally V; Hofbauer JP; Bauer JW; Cathomen T; Kocher T; Koller U
    Mol Ther; 2022 Aug; 30(8):2680-2692. PubMed ID: 35490295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe phenotype of junctional epidermolysis bullosa generalised intermediate type caused by homozygous COL17A1:c.505C>T (p.Arg169*) mutation.
    Vaz SO; Dâmaso C; Liu L; Ozoemena L; Mota-Vieira L
    Eur J Dermatol; 2018 Jun; 28(3):412-413. PubMed ID: 29952287
    [No Abstract]   [Full Text] [Related]  

  • 8. Gentamicin Induces Laminin 332 and Improves Wound Healing in Junctional Epidermolysis Bullosa Patients with Nonsense Mutations.
    Kwong A; Cogan J; Hou Y; Antaya R; Hao M; Kim G; Lincoln V; Chen Q; Woodley DT; Chen M
    Mol Ther; 2020 May; 28(5):1327-1338. PubMed ID: 32222156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of phenotypic variability in junctional epidermolysis bullosa.
    Kiritsi D; Kern JS; Schumann H; Kohlhase J; Has C; Bruckner-Tuderman L
    J Med Genet; 2011 Jul; 48(7):450-7. PubMed ID: 21357940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digenic junctional epidermolysis bullosa: mutations in COL17A1 and LAMB3 genes.
    Floeth M; Bruckner-Tuderman L
    Am J Hum Genet; 1999 Dec; 65(6):1530-7. PubMed ID: 10577906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis Bullosa.
    Ablinger M; Lettner T; Friedl N; Potocki H; Palmetzhofer T; Koller U; Illmer J; Liemberger B; Hainzl S; Klausegger A; Reisenberger M; Lambert J; Van Gele M; Desmet E; Van Maelsaeke E; Wimmer M; Zauner R; Bauer JW; Wally V
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acid duplication in the coiled-coil structure of collagen XVII alters its maturation and trimerization causing mild junctional epidermolysis bullosa.
    Kroeger JK; Hofmann SC; Leppert J; Has C; Franzke CW
    Hum Mol Genet; 2017 Feb; 26(3):479-488. PubMed ID: 28365758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of the cytoplasmatic domain of BP180/collagen XVII causes a phenotype with predominant features of epidermolysis bullosa simplex.
    Huber M; Floeth M; Borradori L; Schäcke H; Rugg EL; Lane EB; Frenk E; Hohl D; Bruckner-Tuderman L
    J Invest Dermatol; 2002 Jan; 118(1):185-92. PubMed ID: 11851893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel homozygous and compound heterozygous COL17A1 mutations associated with junctional epidermolysis bullosa.
    Floeth M; Fiedorowicz J; Schäcke H; Hammami-Hausli N; Owaribe K; Trüeb RM; Bruckner-Tuderman L
    J Invest Dermatol; 1998 Sep; 111(3):528-33. PubMed ID: 9740252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New versatile monoclonal antibodies against type XVII collagen endodomain for diagnosis and subtyping COL17A1-associated junctional epidermolysis bullosa.
    Yuen WY; Di Zenzo G; Jonkman MF; Pas HH
    J Eur Acad Dermatol Venereol; 2016 Aug; 30(8):1426-7. PubMed ID: 26334130
    [No Abstract]   [Full Text] [Related]  

  • 16. Autosomal dominant junctional epidermolysis bullosa.
    Almaani N; Liu L; Dopping-Hepenstal PJ; Lovell PA; Lai-Cheong JE; Graham RM; Mellerio JE; McGrath JA
    Br J Dermatol; 2009 May; 160(5):1094-7. PubMed ID: 19120338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case of non-Herlitz junctional epidermolysis bullosa with COL17A1 mutation.
    Kasai H; Sasaki T; Matsuzaki H; Yoshioka T; Nagao K; Amagai M; Ishiko A; Kubo A
    J Dermatol; 2015 Mar; 42(3):323-5. PubMed ID: 25573436
    [No Abstract]   [Full Text] [Related]  

  • 18. Gentamicin induces
    Lincoln V; Cogan J; Hou Y; Hirsch M; Hao M; Alexeev V; De Luca M; De Rosa L; Bauer JW; Woodley DT; Chen M
    Proc Natl Acad Sci U S A; 2018 Jul; 115(28):E6536-E6545. PubMed ID: 29946029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three novel homozygous point mutations and a new polymorphism in the COL17A1 gene: relation to biological and clinical phenotypes of junctional epidermolysis bullosa.
    Schumann H; Hammami-Hauasli N; Pulkkinen L; Mauviel A; Küster W; Lüthi U; Owaribe K; Uitto J; Bruckner-Tuderman L
    Am J Hum Genet; 1997 Jun; 60(6):1344-53. PubMed ID: 9199555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Fluorescence-Based Screen of Gene Editing Molecules for Junctional Epidermolysis Bullosa.
    Zwicklhuber J; Kocher T; Liemberger B; Hainzl S; Bischof J; Strunk D; Raninger AM; Gratz I; Wally V; Guttmann-Gruber C; Hofbauer JP; Bauer JW; Koller U
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.